A retrospective, cross-sectional study comparing the efficacy of perioperative intravitreal injections of conbercept and ranibizumab for severe proliferative diabetic retinopathy
Latest Information Update: 08 Sep 2020
At a glance
- Drugs Conbercept (Primary) ; Ranibizumab (Primary)
- Indications Diabetic retinopathy
- Focus Therapeutic Use
- 08 Sep 2020 New trial record